Anne Beate Vereide

Treatment results of endometrial hyperplasia after prospective D-score classification

Anne Ørbo, Marit Arnes, Christine Hancke et al. · Gynecologic Oncology · 2008 · 96 citations

Clinical Endpoint, Gynecology, Prospective D-score Classification +3

Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-α and ER-β) in human endometrial hyperplasia

Anne Beate Vereide, Turid Kaino, Georg Sager et al. · Gynecologic Oncology · 2005 · 93 citations

Estrogen Receptors, Myometrial Contractility, Hormonal Contraceptive +14

Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy

Anne Beate Vereide, Turid Kaino, Georg Sager et al. · Gynecologic Oncology · 2005 · 56 citations

Medicine, Endometrial Hyperplasia, Pathology +2

Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the “cisplatin era”

Olesya Solheim, Claes G. Tropé, Erik Rokkones et al. · Gynecologic Oncology · 2014 · 46 citations

Fertility, Female Infertility, Medicine +12

High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis.

Bjørn Moe, Anne Beate Vereide, Georg Sager · PubMed · 2009 · 33 citations

High Concentrations, Hormonal Contraceptive, Apoptosis +20